scispace - formally typeset
M

Moom Sinn Aw

Researcher at University of Adelaide

Publications -  38
Citations -  2486

Moom Sinn Aw is an academic researcher from University of Adelaide. The author has contributed to research in topics: Drug delivery & Drug carrier. The author has an hindex of 24, co-authored 38 publications receiving 2183 citations. Previous affiliations of Moom Sinn Aw include University of South Australia.

Papers
More filters
Journal ArticleDOI

Biocompatible polymer coating of titania nanotube arrays for improved drug elution and osteoblast adhesion.

TL;DR: Results suggest that polymer-modified implants with a TNT layer are capable of delivering a drug to a bone site over an extended period and with predictable kinetics, and favourable bone cell adhesion suggests that such an implant would have good biocompatibility.
Journal ArticleDOI

Surface functionalisation of diatoms with dopamine modified iron-oxide nanoparticles: toward magnetically guided drug microcarriers with biologically derived morphologies

TL;DR: The application of magnetised diatoms as magnetically guided drug delivery microcarriers has been demonstrated in diatom silica microcapsules prepared by purification of diatomaceous earth.
Journal ArticleDOI

Porous silica microshells from diatoms as biocarrier for drug delivery applications

TL;DR: The use of porous silica microshells (microparticles) generated from fossilised diatoms known as diatomite or diatomaceous earth (DE) as a natural drug carrier for drug delivery application is presented in this article.
Journal ArticleDOI

Titania nanotube arrays for local drug delivery: recent advances and perspectives.

TL;DR: TNTs are a remarkable material that could potentially revolutionize localized DD therapies, especially in areas of orthopedics and localized chemotherapy, but more extensive ex vivo and in vivo studies should be carried out before TNTs-based DRI could become a feasible technology for real-life clinical applications.
Journal ArticleDOI

Tuning drug loading and release properties of diatom silica microparticles by surface modifications.

TL;DR: It was found that hydrophilic surfaces of DE microparticles, due to the presence of polar carboxyl, amine or hydrolyzed epoxy group, favor extended release of indomethacin, while the hydrophobic DE surface modified by organic hydrocarbons gives a better sustained release profile for gentamicin.